top of page

BERNA BIOTECH PHARMA GMBH IN THE MEDIA

May 06, 2021: Berna Biotech Pharma GmbH and Swiss Biotech Center to develop second-generation COVID-19 Vaccine
[read more]

Berna Biotech Pharma GmbH

c/o Glück-Spagnoli Lucia, Chasseralstrasse 156, 3095 Spiegel b. Bern

Dipl. Ing. Michael Claus Kuhn, CEO and Managing Partner

m.kuhn@berna-swiss.com  

© 2021 by Berna Biotech Pharma GmbH

bottom of page